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Reply to the Editor:
I appreciate the letter by Rosenfeldt and col-
leagues, and I fully agree that prevention of
vein graft disease is the first step to improve
vein graft longevity. In addition to using a
surgical no-touch technique, Souza and col-
leagues1 recently presented long-term data on
the superior performance of saphenous veins
that were harvested with their surrounding
tissue. The ischemic time of the harvested
vein and the type of storage medium play a
role too. Furthermore, we have to keep in
mind that the greater the target vessel diam-
eter the better the vein graft longevity.
Rosenfeldt and colleagues focus on the prob-
lem of dilation of the saphenous veins before
implantation, which inevitably leads to en-
dothelial injury (and stretch-induced apo-
ptosis of vascular cells). Their concept of
pharmacologic (instead of mechanical) dila-
tion of the saphenous veins in coronary artery
bypass grafting seems to be a rational con-
cept. However, single preventive or therapeu-
tic strategies against vein graft disease are
insufficient. Thus, a combination of mea-
surements seems worthwhile. A variety of
models of vein graft disease have taught us
pathologic features of vein graft disease.2
Nevertheless, only a couple of therapeutic
interventions (systemic pharmacotherapy)
have reached clinical practice (mainly as-
pirin and statins). Thus, an additional local
therapy of the vein graft might be an at-
tractive option to fulfill the armamentarium
of the cardiac surgeon against vein graft
degeneration (Figure 1).
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To the Editor:
We appreciate Dr Chitwood’s insightful edi-
torial1 concerning our report on endoscopic
robotic mitral valve surgery.2 We disagree,
however, with his opinion concerning the
capability of the patient-side assistant in ro-
botic mitral valve surgery. Chitwood states
the “ideal robotic mitral” should be per-
formed completely robotically from the op-
erative console because “a port incision less
than 4 cm does not facilitate extracorporeal
knot tying or other cardiac manipulations.” In
our clinical experience we have not found
this observation to be true. As we reported,
the patient-side assistant using shafted instru-
ments plays an important role in our endo-
scopic robotic technique, both enhancing
valve exposure and facilitating valve repair.
In fact, extracorporeal suture tying by the
patient-side assistant using a closed loop knot
pusher has become our routine because it is
faster and more consistent in our experience
than robotic tying by the console surgeon.
How could 2 clinically experienced robotic
mitral surgery teams have such a different
perception of the capability of the patient-
side assistant? We believe the answer relates
to a critical difference in the port incision
locations between our respective robotic mi-
tral techniques. Chitwood uses a single infra-
mammary fold incision for both endoscope
insertion and patient-side assistant access.3
By using straight, shafted, handheld instru-
ments passed immediately adjacent and
nearly parallel to a 30-degree up endoscope,
we believe conflicts are inherent for Chit-
wood’s assistant attempting to reach valvular
structures. We use separate ports for the en-
doscope and the assistant’s access and locate
these ports substantially more laterally on the
chest wall than Chitwood’s technique. By
separating these 2 ports and moving them
laterally we exploit the natural curvature of
the thoracic cage to compensate for the dif-
ference between the angled endoscope and
the assistant’s straight instruments. This ori-
entation minimizes instrument conflicts and
facilitates the assistant’s ability to reach the
valvular structures directly. In our initial ex-
perience this assistant access port was
slightly less than 4 cm, but now with the
newer robotic system this port incision has
been reduced to 2 cm (Figure 1). Our patient-
side assistant continues to play an active role
in valve repair through this smaller port.
From the standpoint of patient care, it has
been the quality of the knots that has been
clinically relevant, not which member of the
surgical team tied them. Although the surgi-
cal technique we describe may or may not be
“real endoscopic cardiac surgery,” it has per-
mitted us to achieve a higher mitral valve
repair rate with minimal invasion.
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Figure 1. Strategies to fight vein graft
disease.
Figure 1. Endoscopic robotic ports. S, Pa-
tient-side assistant’s port; R, right robotic
instrument arm; L, left robotic instrument
arm; E, robotic endoscope; A, robotic atrial
retractor arm.
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